Catalyst Wire Dossier Catalyst Wire Dossier

Telaprevir (VX-950)

telaprevir · Vertex Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Telaprevir (VX-950), covering 2011-07-21 to 2011-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) [Phase 2]

See pricing